First-of-Kind Stem Cell-Based Tx Being Tested for Retinitis Pigmentosa – Monthly Prescribing Reference (registration)
|
First-of-Kind Stem Cell-Based Tx Being Tested for Retinitis Pigmentosa
Monthly Prescribing Reference (registration) Scientists from University of California Irvine's Gavin Herbert Eye Institute and Sue & Bill Gross Stem Cell Research Center announced the start of patient enrollment for the first clinical trial evaluating the use of retinal progenitor cells to treat … |
